1. Home
  2. TMCI vs HPS Comparison

TMCI vs HPS Comparison

Compare TMCI & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.70

Market Cap

401.8M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Preferred Income Fund III Preferred Income Fund III

HPS

John Hancock Preferred Income Fund III Preferred Income Fund III

HOLD

Current Price

$14.89

Market Cap

480.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
HPS
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
401.8M
480.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TMCI
HPS
Price
$2.70
$14.89
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$7.07
N/A
AVG Volume (30 Days)
1.2M
58.4K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
8.62%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$218,879,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$1.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.90
N/A
52 Week Low
$2.56
$11.79
52 Week High
$10.79
$15.40

Technical Indicators

Market Signals
Indicator
TMCI
HPS
Relative Strength Index (RSI) 21.78 41.35
Support Level $2.56 $14.81
Resistance Level $3.15 $15.03
Average True Range (ATR) 0.23 0.17
MACD 0.05 -0.01
Stochastic Oscillator 12.83 24.42

Price Performance

Historical Comparison
TMCI
HPS

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About HPS John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.

Share on Social Networks: